Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

A University of Massachusetts Amherst public health researcher has received four grants totaling $17.9 million from the National Institutes of Health (NIH) to continue groundbreaking research that ...

Anemia is a common complication of HIV. There are numerous possible causes, including HIV itself, related infections, and some HIV medications. Taking certain medications and adjusting nutrition may ...

Research into this new way of treating HIV is only beginning. When it was first named in 1983, HIV was thought to be a death sentence. The virus replicated rapidly in the people it infected because ...